Prevalence and Persistent Fatigue among Patients Post COVID-19 in Erbil City
DOI:
https://doi.org/10.15218/ejnm.2023.13Keywords:
Post Covid-19 Fatigue, COVID-19, Chronic Fatigue SyndromeAbstract
Background and objectives: Fatigue is one of the most common symptoms, affecting more than 75% of people. It is a subjective lack of physical or mental energy. The goal of the study was to assess persistent fatigue among patients Post-COVID-19 in Erbil city.
Methods: A quantitative, descriptive cross-sectional study was conducted at a private clinic and home for patients in Erbil city. A nonprobability-purposive sample was selected for 300 Post-covid patients. Data was collected through interviews using a questionnaire, and a modified fatigue impact scale was used to assess patients’ fatigue in post-COVID-19.
Results: The results show that one third (31.7%) of the study samples were older than 50 years, and more than half (52.3%) were males, less than one third (28.3%) graduated from an institute, and more than one third (32.3%) were housewives. The majority of the samples (84.7%) lived in areas, and almost all the samples (81.7%) were married. Most of the samples (73.0%) without comorbidity disease about 75.3 were overweight, and the samples (83.0%) were not hospitalized during COVID-19, about more than half (67.0%) were not received oxygen. Less than half (46.3%) of the samples have physical fatigue, and more than half (63.7%) have mild mental fatigue. There was a significant association between fatigue and gender, hospitalization, and receiving oxygen during COVID-19 at P-value ≤ 0.05.
Conclusion: The study concluded that the participants have physical and mental fatigue and physical and mental fatigues are decreasing by increasing the duration of illness from the first to the sixth month. A significant difference was found between fatigue and the female gender.
Metrics
References
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmun-ity. 2020 May 1;109:102433.
Qian Q, Asinger PA, Lee MJ, Han G, Mizrahi Rodriguez K, Lin S, et al. MOF-based mem-branes for gas separations. Chemical re-views. 2020 Jul 1;120(16):8161-266.
Mahase E. China coronavirus: WHO declares international emergency as death toll ex-ceeds 200. BMJ: British Medical Journal (Online). 2020 Jan 31;368.
Li R, Wang W, El-Sayed ES, Su K, He P, Yuan D. Ratiometric fluorescence detection of tetracycline antibiotic based on a polynucle-ar lanthanide metal–organic framework. Sensors and Actuators B: Chemical Refining Laboratory. 2021 Mar 1;330:129314.
Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: Incidence, clinical spec-trum, and challenges for primary healthcare professionals. Archives of medical research. 2021 Aug 1;52(6):575-81.
Gunnell D, Appleby L, Arensman E, Hawton K, John A, Kapur N, et al. Suicide risk and prevention during the COVID-19 pandemic. The Lancet Psychiatry. 2020 Jun 1;7(6):468-71.
Mardani R, Vasmehjani AA, Zali F, Gholami A, Nasab SD, Kaghazian H, et al. Laboratory parameters in detection of COVID-19 pa-tients with positive RT-PCR; a diagnostic ac-curacy study. Archives of academic Emergen-cy medicine. 2020;8(1).
Galloway SE, Paul P, MacCannell DR, Johans-son MA, Brooks JT, MacNeil A, et al. Emer-gence of SARS-CoV-2 b. 1.1. 7 lineage—united states, december 29, 2020–january 12, 2021. Morbidity and Mortality Weekly Report. 2021 Jan 1;70(3):95. Available from https://doi.org/10.15585%2Fmmwr.mm7003e2.
[9] Calabria M, García-Sánchez C, Grunden N, Pons C, Arroyo JA, Gómez-Anson B, et al. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. Journal of neurology. 2022 Apr 30:1-0.
COVID-19: Dashboard- GOV.KRD [Internet]. Kurdistan Regional Government. [Cited 2021 Dec 11]. Available from: https://gov.krd/coronavirus/dashboard
Larson RD. Psychometric properties of the modified fatigue impact scale. Internation-al journal of Multiple sclerosis care. 2013;15(1):15-20.
Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, et al. Post‐COVID syn-drome: A single‐center questionnaire study on 1007 participants recovered from COVID‐19. Journal of Medical Virology. 2021 Dec;93(12):6566-74.
Jabali MA, Alsabban AS, Bahakeem LM, Zwawy MA, Bagasi AT, Bagasi HT, et al. Persistent Symptoms Post-COVID-19: An Observational Study at King Abdulaziz Medical City, Jeddah, Saudi Arabia. Cureus. 2022 Apr 21;14(4).
Mizrahi B, Shilo S, Rossman H, Kalkstein N, Marcus K, Barer Y, et al. Longitudinal symp-tom dynamics of COVID-19 infection. Na-ture communications. 2020 Dec 4;11(1):1-0.
Simani L, Ramezani M, Darazam IA, Sa-gharichi M, Aalipour MA, Ghorbani F, et al. Prevalence and correlates of chronic fa-tigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. Journal of neurovirology. 2021 Feb;27(1):154-9.
Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in sur-vivors of COVID‐19 infection: a cross‐sectional evaluation. Journal of medical virology. 2021 Feb;93(2):1013-22.
Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E, Zaffagnini A, et al. Determi-nants of persistence of symptoms and im-pact on physical and mental wellbeing in Long COVID: A prospective cohort study. Journal of Infection. 2022 Apr 1;84(4):566-72.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospi-talized patients with 2019 novel corona-virus–infected pneumonia in Wuhan, Chi-na. Jama Internal Medicine. 2020 Mar 17;323(11):1061-9.
[19] Sagherian K, Steege LM, Cobb SJ, Cho H. Insomnia, fatigue and psychosocial well‐being during COVID‐19 pandemic: A cross‐sectional survey of hospital nursing staff in the United States. Journal of Clinical nurs-ing. 2020 Nov 20.
Abdelhafiz AS, Ali A, Maaly AM, Mahgoub MA, Ziady HH, Sultan EA. Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminat-ed. PloS one. 2022 Mar 31;17(3):e0266175.
Munblit D, Bobkova P, Spiridonova E, Shi-khaleva A, Gamirova A, Blyuss O, et al. Inci-dence and risk factors for persistent symp-toms in adults previously hospitalized for COVID‐19. Clinical & Experimental Allergy. 2021 Sep;51(9):1107-20.
Morgul E, Bener A, Atak M, Akyel S, Aktaş S, Bhugra D, et al. COVID-19 pandemic and psychological fatigue in Turkey. International Journal of Social Psychiatry. 2021 Mar;67(2):128-35.
Teng Z, Wei Z, Qiu Y, Tan Y, Chen J, Tang H, et al. Psychological status and fatigue of frontline staff two months after the COVID-19 pandemic outbreak in China: A cross-sectional study. Journal of affective disor-ders. 2020 Oct 10;275:247.
El Sayed S, Shokry D, Gomaa SM. Post‐COVID‐19 fatigue and anhedonia: A cross‐sectional study and their correlation to post‐recovery period. Neuropsychopharmacology Reports. 2021 Mar;41(1):50-5. Available from https://doi.org/10.1002/npr2.12154.
Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post‐COVID‐19 manifestations. International jour-nal of clinical practice. 2021 Mar;75(3):e13746.
Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. Morbidity and Mortality Weekly Report. 2020 Jul 7;69(30):993.
González-Hermosillo JA, Martínez-López JP, Carrillo-Lampón SA, Ruiz-Ojeda D, Herrera-Ramírez S, Amezcua-Guerra LM, et al. Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fa-tigue syndrome: a 6-month survey in a Mexi-can cohort. Brain Sciences. 2021 Jun;11(6):760.
Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, et al. Persistent post–COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Annals of the American Thoracic Society. 2021 May;18(5):799-806.
Morin L, Savale L, Pham T, Colle R, Figueire-do S, Harrois A, et al. Four-month clinical status of a cohort of patients after hospitali-zation for COVID-19. Jama. 2021 Apr 20;325(15):1525-34. Available at https://jamanetwork.com/journals/jama/article-abstract/2777787
Khatib S, Sabobeh T, Habib A, John S, Gomez R, Sivasankar S, et al. Post-COVID-19 fatigue as a major health problem: a cross-sectional study from Missouri, USA. Irish Journal of Medical Science (1971-). 2022 Apr 18:1-7.
Ezzat MM, Elsherif AA. Prevalence of fa-tigue in patients post COVID-19. European Journal of Molecular & Clinical Medicine. 2021 Mar 21;8(3):1330-40.
Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fa-tigue following SARS-CoV-2 infection is com-mon and independent of severity of initial infection. PloS one. 2020 Nov 9;15(11):e0240784.
Calabria M, García-Sánchez C, Grunden N, Pons C, Arroyo JA, Gómez-Anson B, et al. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. Journal of neurology. 2022 Apr 30:1-0.
Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, et al. Post-acute COVID-19 syndrome negatively im-pacts physical function, cognitive function, health-related quality of life, and participa-tion. American Journal of Physical Medicine & Rehabilitation. 2022 Jan;101(1):48.
Diem L, Fregolente-Gomes L, Warncke JD, Hammer H, Friedli C, Kamber N, et al. Fa-tigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Associa-tion With Initial Course of COVID-19. Journal of Central nervous system disease. 2022 May 21;14:11795735221102727.
Tomar BS, Singh M, Nathiya D, Sharma A, Sharma E, Bareth H, et al. Prevalence of symptoms in patients discharged from COVID care facility of NIMS hospital: Is RT PCR negativity truly reflecting recovery? A single-centre observational study. Interna-tional journal of general medicine. 2021;14:1069.
Tosato M, Carfì A, Martis I, Pais C, Ciciarello F, Rota E, et al. Prevalence and predictors of persistence of COVID-19 symptoms in older adults: a single-center study. Journal of the American Medical Directors Association. 2021 Sep 1;22(9):1840-4.
Ganesh R, Ghosh AK, Nyman MA, Croghan IT, Grach SL, Anstine CV, et al. PROMIS scales for assessment of persistent post-COVID Symptoms: a cross sectional study. Journal of Primary Care & Community Health. 2021 Jul;12:21501327211030413.
Leth S, Gunst JD, Mathiasen V, Hansen K, Søgaard O, Østergaard L, et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. IN Open forum infec-tious diseases 2021 Apr (Vol. 8, No. 4, p. ofab042). Available from https://doi.org/10.1093/ofid/ofab042
Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Interna-tional Journal of Environmental Research and Public Health. 2021 Feb;18(4):2030.
Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised pa-tients with COVID-19: a longitudinal pro-spective cohort study. The Lancet Regional Health-Europe. 2021 Jul 1;6:100122.
Garout MA, Saleh SA, Adly HM, Abdulkhaliq AA, Khafagy AA, Abdeltawab MR, et al. Post‐COVID-19 syndrome: assessment of short-and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection. 2022 Mar 16:1-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Shagul Hasan Hussein, Ronak Nihmatala Hussain (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
